Skip to main content Skip to main navigation menu Skip to site footer

Medicinal Plants - A Promising Breakthrough in the Management of Alzheimer's Disease Progression Compared to NSAID: A Systematic Review

  • Paulus Sugianto ,
  • Widiana Ferriastuti ,
  • Kiking Ritarwan ,
  • Dwi Putri Rahayu Tampubolon ,


Abstract

Treatment of Alzheimer's Disease is currently limited only to slowing the progression of the symptoms, not curing the disease. Current FDA-approved therapies such as Donepezil, Tacrine, Galantamine, Rivastigmine, and Memantine have quite disturbing side effects, as well as the mechanism of action of these drugs, which is dominated by working as AChE inhibitors. On the other hand, the hypothesis for Alzheimer's causes is varied. Another study also states that Non-Steroid Anti-Inflammatory Drugs (NSAIDs) can be given to people with Alzheimer's. However, the reports were conflicting as one study stated that NSAIDs can help reduce the risk of Alzheimer's; on the contrary, other studies have argued that giving NSAIDs to people with Alzheimer's is not necessary. Despite administering Alzheimer's drugs and NSAIDs, which have adverse side effects on long-term use and high doses, the administration of traditional medicines and medicinal plants can be a good solution due to lower side effects than common drugs, less risk, easy access and affordable. These medicinal plants have several mechanisms to counter the hypothesis that causes Alzheimer's disease.

Keywords: Alzheimer disease Herbal medicine NSAID Medicinal plant

References

  1. Riswanto AK, Sihombing WA, Haryono Y. An Indonesian elderly with primary progressive aphasia and behavioral variant of frontotemporal dementia: A case report and review article. Ann Med Surg [Internet]. 2022 Sep;81:104545. Available from: https://linkinghub.elsevier.com/retrieve/pii/S204908012201305X
  2. Bird TD. Alzheimer Disease Overview 1 . Clinical Characteristics of Alzheimer Disease. Gene Rev. 2018;1–12.
  3. Apostolova LG. Alzheimer disease. In: Handbook of Clinical Neurology [Internet]. 2018. p. 325–37. Available from: https://linkinghub.elsevier.com/retrieve/pii/B9780128023952000237
  4. Kinney JW, Bemiller SM, Murtishaw AS, Leisgang AM, Salazar AM, Lamb BT. Inflammation as a central mechanism in Alzheimer's disease. Alzheimer's Dement Transl Res Clin Interv. 2018;4:575–90.
  5. Roy A. Role of medicinal plants against Alzheimer's disease. Int J Complement Altern Med [Internet]. 2018;11(4):205–8. Available from: https://medcraveonline.com/IJCAM/role-of-medicinal-plants-against-alzheimerrsquos-disease.html
  6. Potshangbam AM, Nandeibam A, Amom T, Potshangbam N, Rahaman H, Rathore RS, et al. An in silico approach to identify potential medicinal plants for treating Alzheimer disease: a case study with acetylcholinesterase. J Biomol Struct Dyn [Internet]. 2022 Mar 4;40(4):1521–33. Available from: https://doi.org/10.1080/07391102.2020.1828170
  7. Cui X, Lin Q, Liang Y. Plant-Derived Antioxidants Protect the Nervous System From Aging by Inhibiting Oxidative Stress. Front Aging Neurosci. 2020;12(July):1–12.
  8. Debnath T, Lee YM, Lim JH, Lim BO, Hrabovsky M, Molecular THE, et al. Nworu and Akah Afr J Tradit Complement Altern Med . ( 2015 ) 12 ( Suppl .): 52-61 ANTI-INFLAMMATORY MEDICINAL PLANTS AND THE MOLECULAR MECHANISMS UNDERLYING THEIR ACTIVITIES Chukwuemeka Sylvester Nworu & Peter Achunike Akah Correspondence : peterakah@hotm. 208 Asian J Pharm Res. 2013;68(1):52–61.
  9. Olajide OA, Sarker SD. Alzheimer's disease: natural products as inhibitors of neuroinflammation. Inflammopharmacology [Internet]. 2020 Dec 15;28(6):1439–55. Available from: https://doi.org/10.1007/s10787-020-00751-1
  10. Mahdi O, Baharuldin MTH, Nor NHM, Chiroma SM, Jagadeesan S, Moklas MAM. Chemicals used for the induction of Alzheimer's disease-like cognitive dysfunctions in rodents. Biomed Res Ther. 2019;6(11):3460–84.
  11. Drugbank. Tacrine [Internet]. 2021. Available from: go.drugbank.com/drugs/DB00382
  12. Alzheimer's Society United Against Dementia. How do drugs for Alzheimer's disease work? [Internet]. 2022. Available from: https://www.alzheimers.org.uk/about-dementia/treatments/drugs/how-do- drugs-alzheimers-disease-work#:~:text=Donepezil%2C%09rivastigmine%09%09and galantamine all,Alzheimer’s disease for a while
  13. Zhang C, Wang Y, Wang D, Zhang J, Zhang F. NSAID Exposure and Risk of Alzheimer's Disease: An Updated Meta-Analysis From Cohort Studies. Front Aging Neurosci [Internet]. 2018 Mar 28;10(MAR):1–9. Available from: http://journal.frontiersin.org/article/10.3389/fnagi.2018.00083/full
  14. Ali MM, Ghouri RG, Ans AH, Akbar A, Toheed A. Recommendations for Anti-inflammatory Treatments in Alzheimer's Disease: A Comprehensive Review of the Literature. Cureus. 2019;11(5).
  15. Farlow M, Gracon SI, Hershey LA, Lewis KW, Sadowsky CH, Dolan Ureno J. A Controlled Trial of Tacrine in Alzheimer's Disease. JAMA J Am Med Assoc. 1992;268(18):2523–9.
  16. Watkins PB. Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease. JAMA J Am Med Assoc [Internet]. 1994 Apr 6;271(13):992–8. Available from: http://jama.ama-assn.org/cgi/doi/10.1001/jama.271.13.992
  17. Sharma K. Cholinesterase inhibitors as Alzheimer's therapeutics (Review). Mol Med Rep. 2019;20(2):1479–87.
  18. Mayo Clinic. Clinic M. Memantine [Internet]. 2021. Available from: mayoclinic.org/drugs-supplements/memantine-oral-route/side- effects/drg-20067012?p=1
  19. Latif F, Imran M. Antioxidants - a combat against oxidative stress in dementia. Ann Med Surg [Internet]. 2022 Oct;82:104632. Available from: https://linkinghub.elsevier.com/retrieve/pii/S2049080122013929
  20. Chen BW, Li WX, Wang GH, Li GH, Liu JQ, Zheng JJ, et al. A strategy to find novel candidate anti-Alzheimer's disease drugs by constructing interaction networks between drug targets and natural compounds in medical plants. PeerJ. 2018;2018(MAY).
  21. Devi P, Syad AN. Botanics: a potential source of new therapies for Alzheimer's disease? Bot Targets Ther. 2014;11.
  22. Li H, Sun X, Yu F, Xu L, Miu J, Xiao P. In Silico Investigation of the Pharmacological Mechanisms of Beneficial Effects of Ginkgo biloba L. on Alzheimer's Disease. Nutrients [Internet]. 2018 May 10;10(5):589. Available from: http://www.mdpi.com/2072-6643/10/5/589
  23. Sharman MJ, Verdile G, Kirubakaran S, Parenti C, Singh A, Watt G, et al. Targeting Inflammatory Pathways in Alzheimer's Disease: A Focus on Natural Products and Phytomedicines. CNS Drugs [Internet]. 2019;33(5):457–80. Available from: https://doi.org/10.1007/s40263-019-00619-1
  24. Kamran M, Kousar R, Ullah S, Khan S, Umer MF, Rashid HU, et al. Taxonomic Distribution of Medicinal Plants for Alzheimer’s Disease: A Cue to Novel Drugs. Int J Alzheimers Dis [Internet]. 2020 Jun 19;2020:1–15. Available from: https://www.hindawi.com/journals/ijad/2020/7603015/
  25. Habtemariam S. Molecular pharmacology of rosmarinic and salvianolic acids: Potential seeds for alzheimer's and vascular dementia drugs. Int J Mol Sci. 2018;19(2).
  26. da Costa IM, de Moura Freire MA, de Paiva Cavalcanti JRL, de Araújo DP, Norrara B, Moreira Rosa IMM, et al. Supplementation with Curcuma longa Reverses Neurotoxic and Behavioral Damage in Models of Alzheimer's Disease: A Systematic Review. Curr Neuropharmacol [Internet]. 2019 Apr 5;17(5):406–21. Available from: http://www.eurekaselect.com/159139/article
  27. Paudel P, Seong SH, Zhou Y, Park CH, Yokozawa T, Jung HA, et al. Rosmarinic acid derivatives' inhibition of glycogen synthase kinase-3β is the pharmacological basis of Kangen-karyu in Alzheimer's disease. Molecules. 2018;23(11):1–14.
  28. Ramírez-Serrano CE, Jiménez-Ferrer E, Herrera-Ruiz M, Zamilpa A, Vargas-Villa G, Ramírez-Carreto RJ, et al. A Malva parviflora's fraction prevents the deleterious effects resulting from neuroinflammation. Biomed Pharmacother [Internet]. 2019 Oct;118(February):109349. Available from: https://doi.org/10.1016/j.biopha.2019.109349
  29. Ahmad B, Hafeez N, Rauf A, Bashir S, Linfang H, Rehman M, et al. Phyllanthus emblica: A comprehensive review of its therapeutic benefits. South African J Bot [Internet]. 2021 May;138:278–310. Available from: https://doi.org/10.1016/j.sajb.2020.12.028
  30. Jamir K, Ganguly R, Seshagirirao K. ZCPG, a cysteine protease from Zingiber montanum rhizome exhibits enhanced anti-inflammatory and acetylcholinesterase inhibition potential. Int J Biol Macromol [Internet]. 2020;163:2429–38. Available from: https://doi.org/10.1016/j.ijbiomac.2020.09.097
  31. Shayganni E, Bahmani M, Asgary S, Rafieian-Kopaei M. Inflammaging and cardiovascular disease: Management by medicinal plants. Phytomedicine [Internet]. 2016 Oct;23(11):1119–26. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0944711315003566
  32. Singh A, Raju R, Münch G. Potential anti-neuroinflammatory compounds from Australian plants – A review. Neurochem Int [Internet]. 2021;142:104897. Available from: https://doi.org/10.1016/j.neuint.2020.104897

How to Cite

Sugianto, P., Ferriastuti, W. ., Ritarwan, K. ., & Tampubolon, D. P. R. . (2022). Medicinal Plants - A Promising Breakthrough in the Management of Alzheimer’s Disease Progression Compared to NSAID: A Systematic Review. Bali Medical Journal, 11(3), 1982–1986. https://doi.org/10.15562/bmj.v11i3.3899
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver
Download Citation
Endnote/Zotero/Mendeley (RIS) BibTeX

HTML
0

Total
0

Share

Search Panel

Paulus Sugianto
Google Scholar
Pubmed
BMJ Journal

Widiana Ferriastuti
Google Scholar
Pubmed
BMJ Journal

Kiking Ritarwan
Google Scholar
Pubmed
BMJ Journal

Dwi Putri Rahayu Tampubolon
Google Scholar
Pubmed
BMJ Journal